None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	of <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-DOSE	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	of <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-DOSE	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	of <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	of <RT_Dosage-START> 30 Gy <RT_Dosage-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6
None	given in 5 fractions , starting week 4 of XRT <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice
None	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 (
None	of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions
None	50.4 Gy is limited to the tumor bed . <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25
None	fractions x 25 fractions , then a <RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions
None	fractions x 25 fractions , then a 5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions
None	<RT_Dosage-START> 5.4 Gy <RT_Dosage-END> final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
DOSE-DOSE	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions
None	5.4 Gy final boost , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions
None	hours of start of chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
DOSE-DOSE	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy )
None	hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_DOSE-START> 12 Gy <RT_DOSE-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> )
None	chemotherapy <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
DOSE-DOSE	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on
None	chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on
None	cm margin to GTV then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
DOSE-DOSE	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with
None	cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with
None	then <RT_Dosage-START> 180 cGy <RT_Dosage-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
DOSE-DOSE	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_DOSE-START> 2.0 Gy <RT_DOSE-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the
None	GTV , total <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
DOSE-DOSE	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions
None	GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions
None	<RT_Dosage-START> 50.4 Gy <RT_Dosage-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in <RT_Dosage-START> 1.5-Gy <RT_Dosage-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : <RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
DOSE-DOSE	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice
None	50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_DOSE-START> 150 cGy <RT_DOSE-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice
None	<RT_Dosage-START> 12 Gy <RT_Dosage-END> ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) <RT_Dosage-START> 2.0 Gy <RT_Dosage-END> x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
DOSE-DOSE	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation
None	12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_DOSE-START> 1200 cGy <RT_DOSE-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation
None	a dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with <RT_Dosage-START> 150 cGy <RT_Dosage-END> fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
DOSE-DOSE	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy (
None	a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions are at least 5 hours apart ) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> (
None	) x 8 fractions ( total dose : <RT_Dosage-START> 1200 cGy <RT_Dosage-END> ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
DOSE-DOSE	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads
None	) x 8 fractions ( total dose : 1200 cGy ) over 4 days on days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads
None	days - 8 to - 5 , with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
DOSE-DOSE	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
DOSE-DOSE	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose :
None	days - 8 to - 5 , with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose :
None	, with lung shielding for the final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
DOSE-DOSE	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
DOSE-DOSE	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5
None	, with lung shielding for the final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5
None	final 600 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
DOSE-DOSE	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
DOSE-DOSE	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1
None	final 600 Gy 1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1
None	<RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
DOSE-DOSE	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5
None	1.5 Gy fractions x 16 fractions , given twice per day x 8 days . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 172 cGy <RT_DOSE-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5
None	consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
DOSE-DOSE	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions
None	consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_DOSE-START> 6020 cGy <RT_DOSE-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions
None	therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
DOSE-DOSE	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over
None	therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over
None	whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 172 cGy <RT_Dosage-END> ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
DOSE-DOSE	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al .
None	whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 172 cGy ( rads ) fractions x 35 fractions , given over 7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al .
None	7 weeks for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
None	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
None	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
DOSE-DOSE	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
DOSE-DOSE	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to
None	7 weeks for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_DOSE-START> 1.8 <RT_DOSE-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to
None	for a total dose of <RT_Dosage-START> 6020 cGy <RT_Dosage-END> ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
DOSE-DOSE	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
DOSE-DOSE	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy )
None	for a total dose of 6020 cGy ( 6020 rads /~ 1700 rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_DOSE-START> 2.25 Gy <RT_DOSE-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> )
None	rets ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
None	rets ) 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
DOSE-DOSE	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
DOSE-DOSE	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
None	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 ,
None	rets ) 2 Gy fractions x 35 fractions ( total dose : 70 Gy ) , given 5 times per week on weeks 1 , 3 , 5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 ,
None	5 , 7 , 9 , 11 , 13 <RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
DOSE-DOSE	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64
None	5 , 7 , 9 , 11 , 13 1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64
None	<RT_Dosage-START> 1.8 <RT_Dosage-END> or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or <RT_Dosage-START> 2.25 Gy <RT_Dosage-END> fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
DOSE-DOSE	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to
None	1.8 or 2.25 Gy fractions x 20 or 25 fractions ( total dose : 45 Gy ) , given over 4 to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_DOSE-START> 60 to 70 Gy <RT_DOSE-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
DOSE-DOSE	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions ,
None	to 5 weeks ; see Northover et al . 2010 for details , including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions ,
None	, including information about boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
DOSE-DOSE	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for
None	, including information about boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_DOSE-START> 30 Gy <RT_DOSE-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for
None	boost radiation therapy <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of
None	boost radiation therapy 2 Gy fractions x 35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of
None	35 fractions ( total dose : <RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25
None	35 fractions ( total dose : 60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25
None	<RT_Dosage-START> 60 to 70 Gy <RT_Dosage-END> ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
DOSE-DOSE	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45
None	60 to 70 Gy ) , given 5 times per week on weeks 1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45
None	1 to 3 , 7 to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
DOSE-DOSE	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200
None	1 to 3 , 7 to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_DOSE-START> 41.4 to 45 Gy <RT_DOSE-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200
None	to 9 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once
None	to 9 2 Gy fractions once per day x 15 fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_DOSE-START> 180 cGy <RT_DOSE-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once
None	fractions ( total dose : <RT_Dosage-START> 30 Gy <RT_Dosage-END> ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
DOSE-DOSE	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy
None	fractions ( total dose : 30 Gy ) 1.2 Gy fractions x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END>
None	x 60 to 64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
DOSE-DOSE	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of
None	x 60 to 64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_DOSE-START> 50 Gy <RT_DOSE-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of
None	64 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
DOSE-DOSE	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	64 fractions 1.8 Gy fractions x 12 fractions 1.8 Gy x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8
None	x 23 to 25 fractions , for an initial dose of <RT_Dosage-START> 41.4 to 45 Gy <RT_Dosage-END> 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy <RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
DOSE-DOSE	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy
None	x 23 to 25 fractions , for an initial dose of 41.4 to 45 Gy 180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_DOSE-START> 45 Gy <RT_DOSE-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END>
None	<RT_Dosage-START> 180 cGy <RT_Dosage-END> in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
DOSE-DOSE	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66
None	180 cGy in 25 fractions , started with cycle 2 2 Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_DOSE-START> 200 cGy <RT_DOSE-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66
None	Gy fractions x 25 fractions , for a total dose of <RT_Dosage-START> 50 Gy <RT_Dosage-END> 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
DOSE-DOSE	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day
None	Gy fractions x 25 fractions , for a total dose of 50 Gy 1.80 Gy fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_DOSE-START> 50 Gy <RT_DOSE-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day
None	fractions x 25 fractions ( total dose : <RT_Dosage-START> 45 Gy <RT_Dosage-END> ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
DOSE-DOSE	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ;
None	fractions x 25 fractions ( total dose : 45 Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ;
None	Gy ) , to start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
DOSE-DOSE	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x
None	Gy ) , to start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_DOSE-START> 59.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x
None	start within 24 hours of cycle 1 day 1 <RT_Dosage-START> 200 cGy <RT_Dosage-END> fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
DOSE-DOSE	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total
None	start within 24 hours of cycle 1 day 1 200 cGy fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total
None	fractions once per day x 25 fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
DOSE-DOSE	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to
None	fractions once per day x 25 fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_DOSE-START> 66 Gy <RT_DOSE-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to
None	fractions ( total dose : <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total
None	fractions ( total dose : 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_DOSE-START> 46 Gy <RT_DOSE-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total
None	: <RT_Dosage-START> 50 Gy <RT_Dosage-END> ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
DOSE-DOSE	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to
None	: 50 Gy ) over 5 weeks , started on cycle 4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to
None	4 day 1 of chemotherapy <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
DOSE-DOSE	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given
None	4 day 1 of chemotherapy 1.8 Gy x 33 fractions ( total dose of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given
None	of <RT_Dosage-START> 59.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
DOSE-DOSE	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	of 59.4 Gy ) 2 Gy fractions x 10 fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days
None	fractions , for a total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
DOSE-DOSE	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	fractions , for a total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total
None	total dose of <RT_Dosage-START> 66 Gy <RT_Dosage-END> ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial <RT_Dosage-START> 46 Gy <RT_Dosage-END> ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
DOSE-DOSE	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	total dose of 66 Gy ( including the initial 46 Gy ) 1.8 Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_DOSE-START> 2 Gy <RT_DOSE-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is
None	Gy per day x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
DOSE-DOSE	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	Gy per day x 28 fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_DOSE-START> 60 to 66 Gy <RT_DOSE-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8
None	fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) <RT_Dosage-START> 2 Gy <RT_Dosage-END> fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
DOSE-DOSE	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole
None	fractions ( total dose : 50.4 Gy ) , given over 5.5 weeks ; see paper for details 1.80 Gy fractions x 28 fractions ( total dose : 50.4 Gy ) 2 Gy fractions x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole
None	x 30 to 33 fractions , for a total dose of <RT_Dosage-START> 60 to 66 Gy <RT_Dosage-END> 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
DOSE-DOSE	x 30 to 33 fractions , for a total dose of 60 to 66 Gy <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV
None	x 30 to 33 fractions , for a total dose of 60 to 66 Gy 1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_DOSE-START> 24 Gy <RT_DOSE-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV
None	<RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
DOSE-DOSE	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
DOSE-DOSE	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	1.5 Gy fractions x 16 fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_DOSE-START> 44.8 Gy <RT_DOSE-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
DOSE-DOSE	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
DOSE-DOSE	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	fractions , given twice per day ( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_DOSE-START> 52.3 Gy <RT_DOSE-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
DOSE-DOSE	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
DOSE-DOSE	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	( 4 to 6 hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_DOSE-START> 64.3 Gy <RT_DOSE-END> . 2.5 Gy fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : 25 Gy ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
DOSE-DOSE	hour interval between treatments ) on days 1 to 5 , 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_DOSE-START> 2.5 Gy <RT_DOSE-END> fractions x 10 fractions ( total dose : <RT_Dosage-START> 25 Gy <RT_Dosage-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all
None	, 8 to 10 . Total dose during consolidation is <RT_Dosage-START> 24 Gy <RT_Dosage-END> . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : <RT_Dosage-START> 44.8 Gy <RT_Dosage-END> ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : <RT_Dosage-START> 52.3 Gy <RT_Dosage-END> ; bladder tumor volume 64.3 Gy . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume <RT_Dosage-START> 64.3 Gy <RT_Dosage-END> . 2.5 Gy fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
DOSE-DOSE	, 8 to 10 . Total dose during consolidation is 24 Gy . Total dose after induction therapy and consolidation therapy : pelvis : 44.8 Gy ; whole bladder : 52.3 Gy ; bladder tumor volume 64.3 Gy . <RT_Dosage-START> 2.5 Gy <RT_Dosage-END> fractions x 10 fractions ( total dose : <RT_DOSE-START> 25 Gy <RT_DOSE-END> ) delivered using IMRT . Gross tumor volume ( GTV ) was all known disease including imaging proven nodal disease . The primary planning target volume ( PTV1 ) included the GTV with 2 - to 3-cm margins in all directions as well as potential nodal involvement . Secondary
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36
None	with 1 - to 1.5-cm margins on all sides including proven nodal involvement . Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_DOSE-START> 54 Gy <RT_DOSE-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4
None	. Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_DOSE-START> 45 <RT_DOSE-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting
None	was <RT_Dosage-START> 54 Gy <RT_Dosage-END> in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in
None	in 28 fractions . Synchronously , PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
DOSE-DOSE	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions
None	, PTV1 and PTV2 received <RT_Dosage-START> 45 <RT_Dosage-END> and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
DOSE-DOSE	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ;
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ;
None	and <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . <RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total
None	<RT_Dosage-START> 4500 cGy <RT_Dosage-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors
None	margin , followed by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
DOSE-DOSE	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	by <RT_Dosage-START> 1080 cGy <RT_Dosage-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
DOSE-DOSE	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	, for a total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
DOSE-DOSE	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given
None	total dose of <RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
DOSE-DOSE	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation
None	<RT_Dosage-START> 5580 cGy <RT_Dosage-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy <RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
DOSE-DOSE	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of
None	<RT_Dosage-START> 36 Gy <RT_Dosage-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_Dosage-START> 4 Gy <RT_Dosage-END> boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
DOSE-DOSE	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy boost to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END>
None	involved fields <RT_Dosage-START> 58 to 66 Gy <RT_Dosage-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to <RT_Dosage-START> 50 Gy <RT_Dosage-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total
None	involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_DOSE-START> 55.8 Gy <RT_DOSE-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total
None	on day 90 to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8
None	on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8
None	to <RT_Dosage-START> 23.4 Gy <RT_Dosage-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in <RT_Dosage-START> 1.80-Gy <RT_Dosage-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions <RT_Dosage-START> 45 Gy <RT_Dosage-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction
None	to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_DOSE-START> 2400 cGy <RT_DOSE-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction
None	<RT_Dosage-START> 1.8 Gy <RT_Dosage-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after
None	1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after
None	to the initial tumor volume ; additional treatment up to a total of <RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician
None	to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician
None	<RT_Dosage-START> 55.8 Gy <RT_Dosage-END> was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for
None	55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_DOSE-START> 28 Gy <RT_DOSE-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_DOSE-START> 72 Gy <RT_DOSE-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a
None	tissue volumes plus a 2 cm margin to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_DOSE-START> 800 cGy <RT_DOSE-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of
None	to <RT_Dosage-START> 2400 cGy <RT_Dosage-END> , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day
None	to 2400 cGy , given during consolidation total dose of 50.4 Gy 18 Gy total given in 10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_DOSE-START> 40.8 Gy <RT_DOSE-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day
None	10 fractions over 12 to 14 days <RT_Dosage-START> 28 Gy <RT_Dosage-END> total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) <RT_Dosage-START> 72 Gy <RT_Dosage-END> 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy <RT_Dosage-START> 800 cGy <RT_Dosage-END> in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
DOSE-DOSE	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END>
None	4 fractions ( days not specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
DOSE-DOSE	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day
None	specified ) <RT_Dosage-START> 40.8 Gy <RT_Dosage-END> ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days
None	to regional lymph nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
DOSE-DOSE	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	nodes given before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
DOSE-DOSE	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
None	before or after surgery at physician discretion : <RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	<RT_Dosage-START> 1.8 to 2.0 Gy <RT_Dosage-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
DOSE-DOSE	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
DOSE-DOSE	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END>
None	total of 23 to 28 fractions , for a total dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times
None	dose of <RT_Dosage-START> 46 to 50.4 Gy <RT_Dosage-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy <RT_Dosage-START> 1.00-Gy <RT_Dosage-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_Dosage-START> 30 Gy <RT_Dosage-END> in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_Dosage-START> 1.8-Gy <RT_Dosage-END> fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_Dosage-START> 10 Gy <RT_Dosage-END> boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
DOSE-DOSE	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy boost to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END>
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_DOSE-START> 45 Gy <RT_DOSE-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_DOSE-START> 1.2 Gy <RT_DOSE-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_DOSE-START> 75 Gy <RT_DOSE-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	the tumor bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_DOSE-START> 40 to 50.4 Gy <RT_DOSE-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_DOSE-START> 18 Gy <RT_DOSE-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> 2.00 Gy fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : 66 Gy )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> fractions x 33 fractions ( total dose : <RT_Dosage-START> 66 Gy <RT_Dosage-END> )
None	bed <RT_Dosage-START> 40 Gy <RT_Dosage-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at <RT_Dosage-START> 1.80 Gy <RT_Dosage-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field <RT_Dosage-START> 59 to 60 Gy <RT_Dosage-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_Dosage-START> 1.5 Gy <RT_Dosage-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of <RT_Dosage-START> 45 Gy <RT_Dosage-END> 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy <RT_Dosage-START> 1.2 Gy <RT_Dosage-END> fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : <RT_Dosage-START> 75 Gy <RT_Dosage-END> ) 40 to 50.4 Gy 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) <RT_Dosage-START> 40 to 50.4 Gy <RT_Dosage-END> 18 Gy 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy <RT_Dosage-START> 18 Gy <RT_Dosage-END> 50.4 Gy 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
None	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy <RT_Dosage-START> 50.4 Gy <RT_Dosage-END> 2.00 Gy fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
DOSE-DOSE	bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy ) 40 to 50.4 Gy 18 Gy 50.4 Gy <RT_Dosage-START> 2.00 Gy <RT_Dosage-END> fractions x 33 fractions ( total dose : <RT_DOSE-START> 66 Gy <RT_DOSE-END> )
